Summary of Key Points Core Viewpoint - The announcement details the upcoming listing and circulation of previously issued shares of Jiujiang Shanshui Technology Co., Ltd., following the approval of the China Securities Regulatory Commission for the company's initial public offering (IPO) and the subsequent release of lock-up shares. Group 1: IPO Overview - The company successfully completed its IPO on December 24, 2021, issuing 53,660,000 shares, increasing the total share capital from 160,976,500 to 214,636,500 shares [1] - Post-IPO, the total share capital consists of 163,744,913 restricted shares (76.29%) and 50,891,587 unrestricted shares (23.71%) [1] Group 2: Share Lock-up and Release - As of the announcement date, the total share capital is 214,636,500 shares, with 71,046,900 unrestricted shares (33.10%) and 143,589,600 restricted shares (66.90%) [3] - The restricted shares, totaling 143,589,600, will be released for circulation starting June 24, 2025 [3] Group 3: Shareholder Commitments - Nine shareholders have made commitments regarding the lock-up of their shares, including a 36-month lock-up period post-IPO and conditions for any future share reductions [4][5] - Shareholders are required to notify the company three trading days in advance before any planned share reductions [8] Group 4: Compliance and Monitoring - The company confirms that all shareholders have adhered to their commitments, and there are no instances of fund occupation or illegal guarantees related to these shareholders [10] - The company will continue to monitor compliance with the commitments made by shareholders regarding share reductions [12] Group 5: Regulatory Approval - The sponsoring institution has verified that the application for the release of restricted shares complies with relevant regulations and that the shareholders have fulfilled their commitments made during the IPO [13]

证券代码：301190 证券简称：善水科技 公告编号：2025-031 九江善水科技股份有限公司 关于首次公开发行前已发行股份上市流通提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、本次上市流通的限售股份为九江善水科技股份有限公司首次公开发行前 已发行的股份。 2、本次解除限售户数为 9 户，股份的数量为 143,589,600.00 股，占总股本 的比例为 66.90%。 3、本次解除限售股份上市流通日为 2025 年 6 月 24 日（星期二）。 一、首次公开发行股份概况 根据中国证券监督管理委员会《关于同意九江善水科技股份有限公司首次公 开发行股票注册的批复》（证监许可[2021]3471 号），九江善水科技股份有限 公司（以下简称"公司"）首次公开发行人民币普通股（A 股）股票 53,660,000 股，于 2021 年 12 月 24 日在深圳证券交易所创业板上市。公司首次公开发行前 总股本为 160,976,500 股，首次公开发行后总股本为 214,636,500 股，其中有限 售条件流通股 163,744,913 股 ...

根据中国证券监督管理委员会《关于同意九江善水科技股份有限公司首次公 开发行股票注册的批复》（证监许可[2021]3471 号），九江善水科技股份有限 公司（以下简称"公司"）首次公开发行人民币普通股（A 股）股票 53,660,000 股，于 2021 年 12 月 24 日在深圳证券交易所创业板上市。公司首次公开发行前 总股本为 160,976,500 股，首次公开发行后总股本为 214,636,500 股，其中有限售 条件流通股 163,744,913 股，占公司发行后总股本的 76.29%，无限售条件流通股 50,891,587 股，占公司发行后总股本的 23.71%。 中原证券股份有限公司 关于九江善水科技股份有限公司 首次公开发行前已发行股份上市流通的核查意见 中原证券股份有限公司（以下简称"中原证券"或"保荐机构"）作为九江 善水科技股份有限公司（以下简称"善水科技"或"公司"）首次公开发行股票 并在创业板上市的保荐机构，根据《证券发行上市保荐业务管理办法》《深圳证 券交易所创业板股票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》及《深圳证券交易所上市公司自律 ...

Core Viewpoint - The company, Shan Shui Technology, is accelerating its industrial scale expansion by signing an investment framework agreement with the Pengze County government to invest approximately 6 billion yuan in a new chemical materials project, which is expected to generate an annual output value of 8 billion yuan and tax revenue of 500 million yuan after completion [1][2]. Group 1: Investment and Project Details - The investment project will be located in the Qishan Industrial Park and will cover an area of about 1,000 acres, focusing on the production of new chemical materials [2]. - The project has an estimated construction period of 4 years, with the aim of enhancing the company's overall competitiveness and expanding its industrial scale [2]. - The agreement encourages the company to collaborate with other capable listed companies for joint investment in the project [1][2]. Group 2: Financial Performance and R&D Investment - In 2024, the company reported a revenue of 505 million yuan, a year-on-year increase of 1.88%, and a net profit of 52.95 million yuan, reflecting a significant growth of 151.51% [5]. - The company's operating costs for 2024 were 370 million yuan, up 16.47% from the previous year, primarily due to increased sales of chlorinated pyridine products [6]. - R&D expenses have consistently increased from 17.99 million yuan in 2021 to 29.00 million yuan in 2024, with year-on-year growth rates of 43.72%, 10%, 30.86%, and 11.94% respectively [7][8]. Group 3: Workforce and Future Plans - As of the end of 2024, the company employed 84 R&D personnel, a 44.83% increase from the previous year, representing 11.88% of the total workforce [9]. - The company plans to continue focusing on technological innovation, safe production, and green environmental practices while managing production operations and investment projects effectively [9].

Group 1: Company Developments - Banu International Holdings Limited submitted its listing application to the Hong Kong Stock Exchange, reporting revenues of 5.639 billion RMB in Q1 2024 and 7.087 billion RMB in Q1 2025, with adjusted net profits of 575 million RMB and 767 million RMB respectively [1] - Midea Group announced a share repurchase plan with a maximum amount of 10 billion RMB and a minimum of 5 billion RMB, aiming to repurchase up to 1 billion shares, which is approximately 1.30% of the total issued shares [6] - *ST Zhongdi plans to transfer its real estate development assets and liabilities to its controlling shareholder for 1 RMB, focusing on property services and asset management for strategic transformation [7] - Muyuan Foods announced that its application for H-share issuance has been accepted by the China Securities Regulatory Commission [8] - *ST Jiuyou's stock will be delisted, with the Shanghai Stock Exchange initiating the delisting process due to significant reporting violations, including a fine of 8.5 million RMB [10] - Weir Shares will change its name to Haowei Group, effective June 20, 2025 [11] - Three squirrels terminated the acquisition of Hunan Ailing Food Technology due to failure to reach agreement on core terms [12] - Bohai Automobile plans to acquire stakes in four automotive parts companies through a combination of share issuance and cash payments [13] - Zhujiang Beer elected a new chairman, Huang Wensheng, following the retirement of the previous chairman [14] Group 2: Industry Trends - The National Medical Products Administration announced measures to support innovative drug development, including a 30-day review process for clinical trial applications [3] - Guangdong Province aims to cultivate 3-5 leading enterprises in the nuclear medicine industry by 2030, enhancing innovation capabilities and establishing a competitive industry cluster [5] - The National Radio and Television Administration is implementing regulations to improve user experience in internet television services, addressing issues related to automatic renewal and user complaints [4] - Shanshui Technology plans to invest 6 billion RMB in a new chemical materials project, expected to generate an annual output value of 8 billion RMB upon completion [19]

Group 1: Stock Resumption - Bohai Automobile plans to acquire 51% equity in Beiqi Moulding, 51% equity in Langfang Andotuo, 100% equity in Zhilian Technology, and 50% equity in Laini Wiring Harness, with stock resuming trading tomorrow [1] - Bangji Technology intends to purchase 100% equity in Beixi Agriculture, Ruido Weili, Xinmu Agriculture, Ruido Agriculture (Lijin), Ruido Agriculture (Shandong), and Weili Agriculture (Binzhou), as well as 80% equity in Paistong through issuing shares and cash payment, with stock resuming trading [1] Group 2: Mergers and Acquisitions - Taihe Intelligent plans to acquire 100% equity in Sunshine Yuchu for no more than 50 million, aiming to expand its energy storage business for commercial users [2] - Wuzhou Xinchun intends to raise no more than 1 billion for the research and industrialization of embodied intelligent robots and core components for automotive intelligent driving [2] Group 3: Share Buybacks - Zhongtong Bus has initiated its first share buyback of 2 million shares [3] - Midea Group plans to repurchase shares worth between 5 billion to 10 billion [6] Group 4: Investment Cooperation and Business Status - Jiangbolong's subsidiary has signed a cooperation memorandum with SanDisk, a globally recognized storage solutions provider with leading storage technology and extensive system design experience [5] - Dazhu CNC has had its application materials for overseas listing shares accepted by the China Securities Regulatory Commission [7] - SanDa Membrane plans to issue H-shares and list on the Hong Kong Stock Exchange [7] - Xinqi Eye Medicine has enrolled the first subject in the Phase III clinical trial for lidocaine eye gel [7] - Shanshui Technology intends to invest 6 billion in a new chemical materials project [7] - China Energy Construction's subsidiary consortium has won a 5 billion EPC general contracting project [7] - Fudan Zhangjiang's injectable FZ-P001 sodium for visualizing malignant lesions during cancer surgery has received clinical trial application acceptance [7] - Yiyuan Lithium Energy plans to extend the reduction of 3.5% shares in Simor International [7] - Lakala is planning to list on the Hong Kong Stock Exchange to accelerate the application of digital currency in cross-border scenarios [7] - Jintaiyang intends to cancel 1.7692 million shares and reduce registered capital accordingly [8] - Aiwei Electronics has developed a low-power high-voltage piezoelectric micro-pump liquid cooling product, marking a breakthrough in domestic chip technology in this field [8] - Redik plans to acquire investment fund shares worth 40 million, focusing on strengthening technology reserves for key components like robotic joint modules [9]

Group 1 - Banqiao Qiancheng signed a significant contract with Mango Film and Television for a total amount of 372 million yuan, accounting for 50.65% of the company's audited main business income for 2024 [1] - The contract allows Mango Film and Television to use the new media and traditional media broadcasting rights for related film and television works globally, positively impacting Banqiao Qiancheng's financial status and operating performance in 2025 and beyond [1] - Jingwei Huikai plans to sell its wholly-owned subsidiary Changsha Yushun for 112 million yuan, which will no longer be included in the consolidated financial statements after the transaction [1] Group 2 - Minsheng Health's subsidiary received a patent for a strain of lactic acid bacteria that significantly improves sarcopenic obesity, although it has not yet been applied to the company's products [2] - Dafu Technology intends to transfer 27% of its subsidiary Shenzhen Peitian Intelligent Manufacturing Equipment Co., Ltd. for 192 million yuan, maintaining a controlling stake post-transaction [3] - Feilong Co. received orders for high-power electronic water pumps for data centers from a well-known global power electronics provider [4] Group 3 - Yatai Co. was selected as a supplier for a foreign brand's EPB project, with a total sales amount of approximately 680 million yuan over a five-year lifecycle [5] - Gansu Energy's 1 million kilowatt wind-solar integrated project has received approval, representing over 10% of the company's installed capacity by the end of 2024 [6] - Jilin Aodong's subsidiary received approval for a drug supplement application for "Tang Le Capsule," used to treat symptoms related to diabetes [7] Group 4 - Shanshui Technology plans to invest 6 billion yuan in a new chemical materials project, expected to generate an annual output value of 8 billion yuan upon completion [8] - Dazhu CNC's H-share issuance application has been accepted by the China Securities Regulatory Commission [9] - Zhujiang Beer announced the resignation of its chairman due to retirement age, with a new chairman elected on the same day [10] Group 5 - Longkun Technology won a bid for a waste collection service project worth 21.57 million yuan, with a service period of one year [11] - Zhongnan Culture plans to provide financial support of up to 20 million yuan to its subsidiary for daily operational needs [12] - Shangfeng Cement's investment in a company applying for an IPO on the Sci-Tech Innovation Board has been accepted [13] Group 6 - Chuanheng Co. received a patent for a system and method for harmless treatment of phosphorus tailings [14] - Toukeng Life's seven medical device registration applications have been accepted, covering various diagnostic fields [15] - Xingqi Eye Medicine's clinical trial for a new eye gel has commenced with the first subject enrolled [16] Group 7 - Jiebang Technology plans to provide financial support of up to 60 million yuan to its subsidiary for operational needs [17] - Shenzhen Airport reported a passenger throughput of 5.54 million in May, a year-on-year increase of 15.67% [18] - Wan'an Technology received a cash dividend of 30 million yuan from its wholly-owned subsidiary [19] Group 8 - Jiuchuan Bio received a medical device registration certificate for a cystatin C assay kit [20] - Hongqiang Co. obtained a safety production license for its subsidiary, marking the official production of a new project [21] - Xiangtan Electric plans to issue convertible bonds totaling 487 million yuan [22] Group 9 - Guangwei Composite signed a supplementary material procurement contract worth 658 million yuan [23] - Jichuan Pharmaceutical announced a comprehensive tender offer starting June 18, with a price of 26.93 yuan per share [24] - Aerospace Rainbow plans to distribute cash dividends of 0.60 yuan per share [25] Group 10 - Industrial Bank plans to distribute cash dividends of 1.06 yuan per share, totaling 22.433 billion yuan [26] - China Automotive Research will repurchase and cancel 230,800 restricted shares due to the retirement of original incentive objects [27] - Annie Co. announced abnormal stock trading fluctuations but confirmed no significant changes in its operations [28] Group 11 - Giant Network confirmed no undisclosed significant matters following abnormal stock trading fluctuations [29]

智通财经6月16日电，善水科技(301190.SZ)公告称，公司与彭泽县人民政府签署《投资框架协议书》， 拟投资60亿元建设化工新材料项目，项目预计建设周期4年，建成后实现年产值80亿元，年纳税5亿元。 善水科技：拟投资60亿元建设化工新材料项目 ...

证券代码：301190 证券简称：善水科技 公告编号：2025-030 九江善水科技股份有限公司 关于签署投资框架协议的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1、本次签署的投资框架协议的项目产能、投资金额、建设周期、土地面积 等均为预计数，相关事项存在一定的不确定性，不构成对投资者的承诺。具体投 资事项明确后，尚须经公司董事会或股东会（如需）审议决议通过。公司将根据 后续各项目进展情况，按照相关法律法规要求履行相应的决策程序和信息披露义 务，敬请投资者注意投资风险。 2、本次签订投资协议的行为不构成关联交易，亦不构成《上市公司重大资 产重组管理办法》中规定的重大资产重组。 3、本次协议的签署对公司当期经营和业绩不产生重大影响，项目建设周期 较长，对未来公司财务状况及经营成果的影响尚不确定。 4、本次投资项目的实施尚需政府部门立项核准及报备、环评审批和施工许 可等前置审批手续，如因国家或地方有关政策调整、项目审批等实施条件因素发 生变化，该项目的实施可能存在变更、延期、中止或终止的风险，存在一定不确 定性。 一、合同签署情况 3、乙方 ...

Group 1 - The company held its 13th meeting of the third Supervisory Board on June 13, 2025, with all three supervisors present, complying with relevant laws and regulations [1] - The Supervisory Board approved the proposal to conclude certain fundraising projects and permanently supplement the remaining funds into working capital, which is deemed reasonable and beneficial for the company's development [1] - The proposal received unanimous approval with 3 votes in favor, and it will be submitted to the shareholders' meeting for further review [2][3] Group 2 - The company also approved a proposal to amend its Articles of Association and related documents to align with the latest laws and regulations, enhancing corporate governance [2] - The amendments include revisions to certain provisions of the current Articles of Association and the corresponding rules, with the Supervisory Board's rules being abolished [2] - This proposal also received unanimous approval with 3 votes in favor and will be submitted to the shareholders' meeting for further review [3]